NCT05200364 · Interventional trial
A Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer
Overall registry status Terminated
Phase 1
Conditions Fallopian Tube Cancer, Ovarian Cancer, Ovarian Carcinoma, Ovary Cancer, Primary Peritoneal Carcinoma
Delaware Valley sites
- University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory